Login
Companies $JRSS
$0.02 -$0.00 (16.67%) Close
JRsis Health Care Corp logo

JRsis Health Care Corp

jhcc.cn

No Longer Reporting

The company has not filed an annual or quarterly report since its Q3 FY2024 10-Q, filed Dec 20, 2024. Its latest SEC filing is a 15-12G from Mar 3, 2025.

The sections below describe the company as of the FY2023 annual report.

What Did They Do?

Builds and sells smart medicine vending equipment and software systems for pharmacies, hospitals and government health projects.

How Did They Make Money?

Sells self-made intelligent terminals and provides installation, maintenance, design and development services for intelligent systems; a related-party reseller buys machines and pays case by case for services at negotiated rates.

FY2023 revenue

Who Were Their Customers?

Customers include government health projects, hospitals, pharmacies and other health-sector businesses. Sales go through a direct sales force and sales agents; a related-party reseller also buys machines and resells them.

Customers above 10% of revenue, FY2022
of revenue from one customer

Did Revenues Turn Into Profits?

Not on paper. It lost $80.9K in FY2023, but brought in more cash than it spent: $515.2K of free cash flow.

Operating income, FY2023
−5% of revenue
▼ −72% (Loss) vs FY2022 (−$684.8K, −40%)
Net income, FY2023
−2% of revenue
▼ −86% (Loss) vs FY2022 (−$575.8K, −33%)
Free cash flow, FY2023
15% of revenue

How Were They Changing?

Since the FY2023 annual report
Latest quarter: Q3 FY2024, the three months to Sep 30, 2024
Revenue
▼ −55%
vs $497.4K in Q3 FY2023
Net income
▼ Now a loss
vs $33.7K in Q3 FY2023

Shrank. Revenue fell 89% in 4 years, from $31.5M in FY2019 to $3.5M in FY2023, about 42% a year.

From hospital care to medical technology Earlier reports describe operating hospitals that treated patients and sold pharmaceuticals; the latest report describes developing and selling smart medicine equipment and related software and services.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support